Abstract

BackgroundCervical cancer is the fourth most common cancer in women. Early detection and diagnosis play an important role in secondary prevention of cervical cancer. This study aims to provide more information to develop an effective strategy for the prevention and control of cervical cancer in northern China.MethodsA retrospective single-centre descriptive cross-sectional study was conducted in Chinese PLA General Hospital located in Beijing, covering the period from January 2009 to June 2019. The patients who underwent a polymerase chain reaction (PCR)-based HPV genotyping test and cervical pathological diagnosis were included. Furthermore, we limited the interval between the two examination within 180 days for the purpose of making sure their correlation to analyse their relationship. Moreover, the relationship between different cervical lesions and age as well as single/multiple HPV infection was assessed.ResultsA total of 3134 patients were eligible in this study after HPV genotyping test and pathological diagnosis. Most of the patients (95%) were from northern China. Among the patients, 1745(55.68%) had high-grade squamous intraepithelial neoplasia (HSIL), 1354 (43.20%) had low-grade squamous intraepithelial neoplasia (LSIL) and 35 (1.12%) were Normal. The mean age was 42.06 ± 10.82(range, 17–79 years). The women aged 35–49 years accounted for the highest incidence rate. The top five most commonly identified HPV genotypes in each lesion class were as follows: HPV16, 58, 52, 31 and 51 in the class of HSIL; HPV16, 52, 58, 56 and 51 in the class of LSIL; HPV16, 31, 6,11, 52 and 58 in the class of normal. The frequencies of HPV single genotype infection and multiple genotypes infection were 55.26 and 34.18%, respectively. There was no difference in the attributable proportions of multiple genotypes infection amongst HSIL, LSIL and Normal.ConclusionsIn Northern China, HPV16 was the most dominant genotype in the patients with pathological examination. The peak age of the onset of HSIL was between 35 and 49 years of age. Infection with multiple HPV genotypes did not increase the risk of HSIL. Type-specific HPV prevalence and attribution proportion to cervical precancerous lesions should be taken into consideration in the development of vaccines and strategy for screening in this population.

Highlights

  • Cervical cancer, a type of malignant genital tract tumour, is the 4th most frequently diagnosed cancer in women worldwide, making it the 4th leading cause of cancer death as well, which greatly threatens women’s lives

  • Infection with multiple Human papilloma virus (HPV) genotypes did not increase the risk of high-grade squamous intraepithelial neoplasia (HSIL)

  • Type-specific HPV prevalence and attribution proportion to cervical precancerous lesions should be taken into consideration in the development of vaccines and strategy for screening in this population

Read more

Summary

Introduction

A type of malignant genital tract tumour, is the 4th most frequently diagnosed cancer in women worldwide, making it the 4th leading cause of cancer death as well, which greatly threatens women’s lives. According to a report which provided global data and graphical visualization of cancer incidence and mortality using the database of GLOBOCAN 2018 produced by the International Agency for Research on Cancer (IARC), there were 569,847 new cases of cervical cancer causing 311,365 deaths globally in 2018 [1]. Based on the data from World Health Organization [3], in China, cervical cancer was responsible for 106,430 new cases and 47,739 deaths in the year of 2018. The prevention and cure of cervical cancer has been one of the major public health problems in China.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call